Section Arrow
LIMN.NASDAQ
- Liminatus Pharma Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/04/09 02:45 EDT
Regular Hours
Last
 0.184
-0.0005 (-0.27%)
Day High 
0.207 
Prev. Close
0.1845 
1-M High
0.27 
Volume 
2.71M 
Bid
0.189
Ask
0.195
Day Low
0.184 
Open
0.1854 
1-M Low
0.1592 
Market Cap 
5.73M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.18 
20-SMA 0.21 
50-SMA 0.44 
52-W High 33.66 
52-W Low 0.1592 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.43/--
Enterprise Value
5.73M
Balance Sheet
Book Value Per Share
-0.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.1831+0.0201+12.33%-- 
VRAXVirax Biolabs Group Limited0.15+0.01+7.14%-- 
ELABPmgc Holdings Inc4.5+1.05+30.43%0PE
CUECue Biopharma0.2738+0.0856+45.48%-- 
GERNGeron Corp1.71-0.03-1.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towardscolorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.